Avelas Biosciences
PrivateLast Round
Accelerator
Jun 17, 2019
Total Funding Raised
$35.05M
Company Overview
Avelas Biosciences operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was an Accelerator round in June 2019.
Avelas Biosciences is a biotechnology company that develops fluorescent imaging technologies for real-time cancer detection and visualization during surgery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avelas Biosciences Comparables
Compare Avelas Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Blaze Bioscience, Inc. | 92% | |
| SurgiMab | 83% | |
| Vergent Bioscience | 81% |
For institutional investors. Book with your work email.
Avelas Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 17, 2019 | ||||
| Series C | Aug 18, 2016 | ||||
| Series B | Sep 10, 2014 | ||||
| Series A | Dec 6, 2012 |
For institutional investors. Book with your work email.
Avelas Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator |
| WuXi Healthcare Ventures | Series C |
| Avalon Ventures | Series C, Series A, Series B |
| Torrey Pines Investment LLC | Series B |
| Alexandria Venture Investments | Series C |
| Pharmstandard International S.A. | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 6, 2012
$7.65M round led by Avalon Ventures
For institutional investors. Book with your work email.
Avelas Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avelas Biosciences's valuation, stock price, and market status.
Is Avelas Biosciences a public or private company?
Avelas Biosciences is a private company.
What is the current stock price of Avelas Biosciences?
Avelas Biosciences is a private company, so its shares have no public market price. Caplight tracks Avelas Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avelas Biosciences worth (valuation)?
Valuation information for Avelas Biosciences is not publicly available.
Can I buy Avelas Biosciences stock?
Avelas Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avelas Biosciences's last funding round?
Avelas Biosciences's most recent funding round was Accelerator on June 17, 2019.
Who are the main investors in Avelas Biosciences?
Key investors in Avelas Biosciences include MedTech Innovator, Avalon Ventures, Pharmstandard International S.A..
Will Avelas Biosciences IPO soon?
No public IPO plans have been announced for Avelas Biosciences.
How can I track Avelas Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Avelas Biosciences's shares on secondary markets.